Literature DB >> 25250696

The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy.

Katherine M Bever1, Elizabeth A Sugar, Elaine Bigelow, Rajni Sharma, Daniel Laheru, Christopher L Wolfgang, Elizabeth M Jaffee, Robert A Anders, Ana De Jesus-Acosta, Lei Zheng.   

Abstract

BACKGROUND: Pancreatic ductal adenocarcinoma (PDA) is comprised of a prominent desmoplastic stromal compartment and only 10-40% of the tumour consists of PDA cells. However, how stromal components should be assessed and how the characteristics of the stromal compartment determine clinical outcomes in PDA patients remain unknown.
METHOD: A cohort of 66 consecutive patients who underwent pancreaticoduodenectomy and were primarily followed at Johns Hopkins Hospital between 1998 and 2004, and treated with adjuvant therapy, were included in a retrospective analysis. Resected PDA blocks with good tissue preservation were available for all patients. A new, computer-aided, quantitative method was developed to assess the density and activity of stroma in PDAs and the associations of these characteristics with clinical outcomes.
RESULTS: High stromal density in resected PDA was found to be significantly associated with longer disease-free [adjusted hazard ratio (aHR) 0.39; P = 0.001] and overall (aHR 0.44; P = 0.004) survival after adjusting for the use of pancreatic cancer vaccine therapy, as well as gender and resection margin positivity. Stromal activity, representing activated pancreatic stellate cells in PDAs, was not significantly associated with the prognosis of resected PDAs.
CONCLUSIONS: These results illustrate the complexity of the role of stroma in PDAs. Further exploration of the prognostic ability of the characteristics of stroma is warranted.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25250696      PMCID: PMC4368391          DOI: 10.1111/hpb.12334

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  15 in total

Review 1.  Unraveling the therapeutic potential of the Hedgehog pathway in cancer.

Authors:  Dereck Amakye; Zainab Jagani; Marion Dorsch
Journal:  Nat Med       Date:  2013-11-07       Impact factor: 53.440

2.  Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha.

Authors:  Matthew Kraman; Paul J Bambrough; James N Arnold; Edward W Roberts; Lukasz Magiera; James O Jones; Aarthi Gopinathan; David A Tuveson; Douglas T Fearon
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

3.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

Authors:  Paolo P Provenzano; Carlos Cuevas; Amy E Chang; Vikas K Goel; Daniel D Von Hoff; Sunil R Hingorani
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

Review 4.  Stromal biology and therapy in pancreatic cancer.

Authors:  Albrecht Neesse; Patrick Michl; Kristopher K Frese; Christine Feig; Natalie Cook; Mike A Jacobetz; Martijn P Lolkema; Malte Buchholz; Kenneth P Olive; Thomas M Gress; David A Tuveson
Journal:  Gut       Date:  2010-10-21       Impact factor: 23.059

5.  A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.

Authors:  Eric Lutz; Charles J Yeo; Keith D Lillemoe; Barbara Biedrzycki; Barry Kobrin; Joseph Herman; Elizabeth Sugar; Steven Piantadosi; John L Cameron; Sara Solt; Beth Onners; Irena Tartakovsky; Miri Choi; Rajni Sharma; Peter B Illei; Ralph H Hruban; Ross A Abrams; Dung Le; Elizabeth Jaffee; Dan Laheru
Journal:  Ann Surg       Date:  2011-02       Impact factor: 12.969

Review 6.  Pancreatic cancer: the role of pancreatic stellate cells in tumor progression.

Authors:  Siri Dunér; Jacob Lopatko Lindman; Daniel Ansari; Chinmay Gundewar; Roland Andersson
Journal:  Pancreatology       Date:  2011-01-18       Impact factor: 3.996

7.  Pancreatic cancer stroma: friend or foe?

Authors:  Jesse Gore; Murray Korc
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

Review 8.  Pancreatic cancer: progress in cancer therapy.

Authors:  Chiara Pierantoni; Alessandra Pagliacci; Mario Scartozzi; Rossana Berardi; Maristella Bianconi; Stefano Cascinu
Journal:  Crit Rev Oncol Hematol       Date:  2008-03-19       Impact factor: 6.312

Review 9.  The role of the tumor microenvironment in the progression of pancreatic cancer.

Authors:  Buckminster Farrow; Daniel Albo; David H Berger
Journal:  J Surg Res       Date:  2008-01-10       Impact factor: 2.192

10.  Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

Authors:  Kenneth P Olive; Michael A Jacobetz; Christian J Davidson; Aarthi Gopinathan; Dominick McIntyre; Davina Honess; Basetti Madhu; Mae A Goldgraben; Meredith E Caldwell; David Allard; Kristopher K Frese; Gina Denicola; Christine Feig; Chelsea Combs; Stephen P Winter; Heather Ireland-Zecchini; Stefanie Reichelt; William J Howat; Alex Chang; Mousumi Dhara; Lifu Wang; Felix Rückert; Robert Grützmann; Christian Pilarsky; Kamel Izeradjene; Sunil R Hingorani; Pearl Huang; Susan E Davies; William Plunkett; Merrill Egorin; Ralph H Hruban; Nigel Whitebread; Karen McGovern; Julian Adams; Christine Iacobuzio-Donahue; John Griffiths; David A Tuveson
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

View more
  32 in total

1.  Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers.

Authors:  Erik S Knudsen; Paris Vail; Uthra Balaji; Hoai Ngo; Ihab W Botros; Vladimir Makarov; Nadeem Riaz; Vinod Balachandran; Steven Leach; Debrah M Thompson; Timothy A Chan; Agnieszka K Witkiewicz
Journal:  Clin Cancer Res       Date:  2017-03-27       Impact factor: 12.531

2.  Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer.

Authors:  Agnieszka A Rucki; Kelly Foley; Pingbo Zhang; Qian Xiao; Jennifer Kleponis; Annie A Wu; Rajni Sharma; Guanglan Mo; Angen Liu; Jennifer Van Eyk; Elizabeth M Jaffee; Lei Zheng
Journal:  Cancer Res       Date:  2016-11-07       Impact factor: 12.701

Review 3.  Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis.

Authors:  Ana C Martins Cavaco; Sara Dâmaso; Sandra Casimiro; Luís Costa
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions.

Authors:  Gianluca Mucciolo; Claudia Curcio; Cecilia Roux; Wanda Y Li; Michela Capello; Roberta Curto; Roberto Chiarle; Daniele Giordano; Maria Antonietta Satolli; Rita Lawlor; Aldo Scarpa; Pavol Lukac; Dmitry Stakheev; Paolo Provero; Luca Vannucci; Tak W Mak; Francesco Novelli; Paola Cappello
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

5.  Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence.

Authors:  Janusz Franco-Barraza; Ralph Francescone; Tiffany Luong; Neelima Shah; Raj Madhani; Gil Cukierman; Essel Dulaimi; Karthik Devarajan; Brian L Egleston; Emmanuelle Nicolas; R Katherine Alpaugh; Ruchi Malik; Robert G Uzzo; John P Hoffman; Erica A Golemis; Edna Cukierman
Journal:  Elife       Date:  2017-01-31       Impact factor: 8.140

Review 6.  Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.

Authors:  Pavan P Adiseshaiah; Rachael M Crist; Sara S Hook; Scott E McNeil
Journal:  Nat Rev Clin Oncol       Date:  2016-08-17       Impact factor: 66.675

7.  A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.

Authors:  Eugene J Koay; Yeonju Lee; Vittorio Cristini; John S Lowengrub; Ya'an Kang; F Anthony San Lucas; Brian P Hobbs; Rong Ye; Dalia Elganainy; Muayad Almahariq; Ahmed M Amer; Deyali Chatterjee; Huaming Yan; Peter C Park; Mayrim V Rios Perez; Dali Li; Naveen Garg; Kim A Reiss; Shun Yu; Anil Chauhan; Mohamed Zaid; Newsha Nikzad; Robert A Wolff; Milind Javle; Gauri R Varadhachary; Rachna T Shroff; Prajnan Das; Jeffrey E Lee; Mauro Ferrari; Anirban Maitra; Cullen M Taniguchi; Michael P Kim; Christopher H Crane; Matthew H Katz; Huamin Wang; Priya Bhosale; Eric P Tamm; Jason B Fleming
Journal:  Clin Cancer Res       Date:  2018-08-06       Impact factor: 12.531

8.  Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.

Authors:  Kelly Foley; Agnieszka A Rucki; Qian Xiao; Donger Zhou; Ashley Leubner; Guanglan Mo; Jennifer Kleponis; Annie A Wu; Rajni Sharma; Qingguang Jiang; Robert A Anders; Christine A Iacobuzio-Donahue; Katherine A Hajjar; Anirban Maitra; Elizabeth M Jaffee; Lei Zheng
Journal:  Sci Signal       Date:  2015-08-04       Impact factor: 8.192

9.  Quantitative phase imaging of stromal prognostic markers in pancreatic ductal adenocarcinoma.

Authors:  Michael Fanous; Adib Keikhosravi; Andre Kajdacsy-Balla; Kevin W Eliceiri; Gabriel Popescu
Journal:  Biomed Opt Express       Date:  2020-02-12       Impact factor: 3.732

10.  Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.

Authors:  Štepán Novák; Michal Kolář; Arpád Szabó; Zdena Vernerová; Lukáš Lacina; Hynek Strnad; Jana Šáchová; Miluše Hradilová; Jan Havránek; Michal Španko; Matúš Čoma; Lukáš Urban; Miriam Kaňuchová; Nikola Melegová; Robert Gürlich; Josef Dvořák; Karel Smetana; Peter Gál; Pavol Szabo
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.